Cagan Koc

Cagan Koc is an Amsterdam Bureau Chief at Bloomberg. He covers technology and politics with a focus on the impact of globalization on European businesses and policy. His primary topics include Philips, ASML, Legrand, ABN Amro, and Thames Water. Cagan has reported on major events such as the US settlement for sleep apnea claims by Philips, Iran's nuclear saber rattling at the UN Watchdog, and insider trading feuds at football giant Ajax. He also covers developments in the semiconductor industry, cyberattacks on Chinese-owned Dutch chipmaker Nexperia, and the potential impact of digital euros on Dutch central banking.

Biography:  https://www.bloomberg.com/authors/ASxM4reY1Qk/cagan-koc

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

ASML Share Value Plummets Amidst Possible US Export Restrictions to China

ASML Share Value Plummets Amidst Possible US Export Restrictions to China

Broke On: Wednesday, 17 July 2024 ASML Holding NV faces potential severe US export restrictions to China, causing a sharp decline in its share value. The Biden administration's push for tighter export controls may prevent the Dutch semiconductor giant from providing advanced technology to Beijing, impacting not only ASML but also other US-based companies. Ongoing trade tensions between China and Taiwan add complexity to the situation, leading investors to sell off ASML shares.
Philips Agrees to $1.1 Billion Settlement Over Cancer Risks in Recalled Sleep Apnea Devices

Philips Agrees to $1.1 Billion Settlement Over Cancer Risks in Recalled Sleep Apnea Devices

Broke On: Monday, 29 April 2024 Philips, a Dutch medical devices company, reached a $1.1 billion settlement in the US to resolve personal injury lawsuits related to its recalled sleep apnea devices made by subsidiary Philips Respironics due to cancer risk concerns. The settlement covers payments expected in 2025 and is funded through cash flow generation, with insurers contributing €540 million for claims. Despite losses of €1.3 billion in 2023-Q1 2024 on sales of €4.1 billion, Philips shares surged following the announcement.